Caladrius Bio (CLBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLBS | ATOS | CVM | ||
| Company | Caladrius Bio | Atossa Therapeutics Inc | Cel-Sci Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE Arca | ||
| Open | 0.6480 | 2.59 | 1.4800 | ||
| High | 0.6500 | 2.62 | 1.4900 | ||
| Low | 0.3820 | 2.51 | 1.4200 | ||
| Last | 0.4264 | 2.54 | 1.4200 | ||
| Change | -0.0839 | -0.05 | -0.0400 | ||
| Percent Change | -16.44% | -1.93% | -2.74% | ||
| Volume | 26,946,600 | 25,567 | 66,121 | ||
| 20-Day Average Volume | 1,469,975 | 60,258 | 212,641 | ||
| Previous | 0.5103 | 2.59 | 1.4600 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.5057 | 2.42 | 1.4270 | ||
| 20-Day Raw Stochastic | 16.57% | 53.27% | 46.14% | ||
| 20-Day Relative Strength | 32.97 | 48.15 | 49.88 | ||
| Weighted Alpha | -64.50 | -60.58 | -82.16 | ||
| Today's Opinion | 88% Sell | 40% Sell | 56% Sell | ||
| Yesterday's Opinion | 88% Sell | 40% Sell | 40% Sell | ||
| Last Month's Opinion | 72% Sell | 88% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -16.39% since 09/07/22 | -2.31% since 08/14/26 | -7.79% since 08/14/26 | ||
| Low | 0.3820 on 09/14/22 | 2.44 on 08/20/26 | 1.4200 on 08/21/26 | ||
| High | 0.6500 on 09/14/22 | 2.97 on 08/17/26 | 1.6900 on 08/19/26 | ||
| 1-Month | |||||
| %Chg | -20.63% since 08/12/22 | +5.83% since 07/21/26 | +13.60% since 07/21/26 | ||
| Low | 0.3820 on 09/14/22 | 2.05 on 07/31/26 | 1.1400 on 07/29/26 | ||
| High | 0.6500 on 09/14/22 | 2.97 on 08/17/26 | 1.7468 on 08/10/26 | ||
| 3-Month | |||||
| %Chg | -14.72% since 06/14/22 | -48.89% since 05/21/26 | -2.07% since 05/21/26 | ||
| Low | 0.3820 on 09/14/22 | 1.70 on 06/25/26 | 0.9600 on 06/25/26 | ||
| High | 0.6500 on 09/14/22 | 5.30 on 05/29/26 | 1.7468 on 08/10/26 | ||
| 6-Month | |||||
| %Chg | -34.40% since 03/14/22 | -39.67% since 02/20/26 | -70.42% since 02/20/26 | ||
| Low | 0.3820 on 09/14/22 | 1.70 on 06/25/26 | 0.8900 on 05/12/26 | ||
| High | 0.7960 on 03/24/22 | 6.28 on 04/20/26 | 4.9500 on 04/17/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 25,833 | 25,846 | 25,516 | ||
| Shares Outstanding, K | 60,583 | 9,979 | 17,477 | ||
| Annual Sales, $M | 0 | 0 | 0 | ||
| Annual Net Income, $M | -27,470,000 | -34,770,000 | -25,410,000 | ||
| Last Qtr Sales, $M | 0 | 0 | 0 | ||
| Last Qtr Income, $M | -6,630,000 | -8,490,000 | -5,670,000 | ||
| 60-Month Beta | 0.91 | 1.29 | 0.63 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.11 on 08/04/22 | -0.95 on 08/07/26 | -0.47 on 08/14/26 | ||
| Latest Earnings Date | 11/03/22 | 11/11/26 | 01/04/27 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||